Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion type Assertion NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_head.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion evidence source_evidence_literature NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion SIO_000772 18339451 NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion wasDerivedFrom befree-20140225 NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.
- NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_assertion wasGeneratedBy ECO_0000203 NP407982.RAm0M8tbQDxFk2ZIXkDz4nwhu4vj3N5qc8L1nhdJgsBVM130_provenance.